Cabrexxa 0,5 & 1 0,5 mg, 1 mg Tablet
PDF Leaflet Revision Date: May 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Aid to smoking cessation in motivated patients.
Dosage (summary)
1 mg twice daily after 1-week titration.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Not recommended in pregnancy or breastfeeding.
Key Drug Interactions
- Warfarin
- Cimetidine
- Alcohol
Contraindications
- Hypersensitivity to varenicline
Common side effects
- Nausea
- Insomnia
- Headache
- Dizziness
Counselling Points
- Monitor for mood changes.
- Do not drive if affected.
- Set a quit date before starting.
Serious warnings
- Serious neuropsychiatric symptoms
- Seizures
- Cardiovascular events
Important Disclaimer
The Cabrexxa 0,5 & 1 0,5 mg, 1 mg Tablet professional information leaflet below is the property of Abex Pharmaceutica and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
